Apigenin inhibits infectious bronchitis virus replication in ovo

Eur Rev Med Pharmacol Sci. 2022 Aug;26(15):5367-5371. doi: 10.26355/eurrev_202208_29403.

Abstract

Objective: Infectious bronchitis virus (IBV), for which no effective drugs are available, is among the most important causes of economic loss within the poultry industry. Apigenin is a flavonoid that can be isolated from plants. Apigenin has low toxicity with anti-viral activity. However, the effects of apigenin against IBV remain unclear.

Materials and methods: Thus, here we investigate the anti-viral effect of apigenin on IBV using 10 day-old embryonated eggs by determining the virus titer by embryo infective doses50 (EID50/mL) and determining IBV genomes copy number (per µL) of allantoic fluid.

Results: We found that apigenin protected embryonated eggs from IBV. Additionally, apigenin reduced the log titer of the IBV with a significant correlation of up to 9.4 times at 2 µg/egg. Also, apigenin appears to significantly reduce IBV genomes copy number (per µL) in the allantoic fluid.

Conclusions: Apigenin may be a promising approach for the treatment of IBV, since it protects embryonated eggs from IBV in ovo and suppresses viral replication.

MeSH terms

  • Animals
  • Apigenin / pharmacology
  • Infectious bronchitis virus*
  • Poultry Diseases*
  • Viral Load
  • Virus Replication

Substances

  • Apigenin